- Home
- LYRA vs MKZR Comparison
LYRA vs MKZR Comparison
Compare LYRA & MKZR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LYRA
- MKZR
- Stock Information
- Founded
- LYRA 2005
- MKZR 2012
- Country
- LYRA United States
- MKZR United States
- Employees
- LYRA N/A
- MKZR N/A
- Industry
- LYRA Medical/Dental Instruments
- MKZR
- Sector
- LYRA Health Care
- MKZR
- Exchange
- LYRA Nasdaq
- MKZR Nasdaq
- Market Cap
- LYRA 11.3M
- MKZR 10.3M
- IPO Year
- LYRA 2020
- MKZR N/A
- Fundamental
- Price
- LYRA $6.85
- MKZR $5.78
- Analyst Decision
- LYRA Hold
- MKZR
- Analyst Count
- LYRA 1
- MKZR 0
- Target Price
- LYRA $16.00
- MKZR N/A
- AVG Volume (30 Days)
- LYRA 14.2K
- MKZR 69.1K
- Earning Date
- LYRA 08-12-2025
- MKZR 09-19-2025
- Dividend Yield
- LYRA N/A
- MKZR 38.99%
- EPS Growth
- LYRA N/A
- MKZR N/A
- EPS
- LYRA N/A
- MKZR N/A
- Revenue
- LYRA $770,000.00
- MKZR $23,037,348.00
- Revenue This Year
- LYRA N/A
- MKZR N/A
- Revenue Next Year
- LYRA $123.46
- MKZR N/A
- P/E Ratio
- LYRA N/A
- MKZR N/A
- Revenue Growth
- LYRA N/A
- MKZR 52.64
- 52 Week Low
- LYRA $3.81
- MKZR $3.89
- 52 Week High
- LYRA $37.50
- MKZR $55.00
- Technical
- Relative Strength Index (RSI)
- LYRA 42.34
- MKZR 50.44
- Support Level
- LYRA $6.91
- MKZR $4.76
- Resistance Level
- LYRA $7.50
- MKZR $6.40
- Average True Range (ATR)
- LYRA 0.33
- MKZR 0.42
- MACD
- LYRA 0.06
- MKZR 0.12
- Stochastic Oscillator
- LYRA 16.18
- MKZR 62.01
About LYRA Lyra Therapeutics Inc.
Lyra Therapeutics Inc is a clinical-stage therapeutics company focused on the development and commercialization of novel integrated drug and delivery solutions for the localized treatment of patients. The Company's operations and manages its business as a single operating segment which is the business of developing targeted medicines to address ears, nose, and throat, or ENT diseases. Its initial product candidates, LYR-210 and LYR-220, are bioabsorbable polymeric matrices designed to be administered in a brief, non-invasive, in-office procedure and intended to deliver continuous drug therapy to the sinonasal passages for the treatment of chronic rhinosinusitis, or CRS.
About MKZR MacKenzie Realty Capital Inc.
Mackenzie Realty Capital Inc is a company which is a Real estate investment trust (REIT). The company has one reportable segment, income-producing real estate properties which consists of activities related to investing in real estate.